Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum SCYNEXIS Inc SCYX

SCYNEXIS, Inc. is a biotechnology company. It is pioneering medicine to overcome and prevent difficult-to-treat and drug-resistant infections. It develops antifungal platform fungerps, a novel class of antifungal agents called triterpenoids, that are structurally distinct glucan synthase inhibitors and have generally shown in vitro and in vivo activity against a range of human fungal pathogens,... see more

NDAQ:SCYX - Post Discussion

SCYNEXIS Inc > Stop Raising Dilutive Funds
View:
Post by dmacd on Sep 17, 2021 5:08pm

Stop Raising Dilutive Funds

Show some progress.before another capital raise. No focus on SP. Winning losers .. grrrrr.
Comment by JonathanJSmith on Sep 20, 2021 8:55am
There's no real capital raise here or dilution (only ~1.3mm shares). They filed the recent S3/prospectuses for a couple of purposes - because the original (written 3 years ago) was expiring, and to let investors know that they can still sell up to ~1.5mm more shares at prevailing prices. The real dilution already occurred with another ~22mm shares/warrants at around $7.77/sh (in the aggregate) ...more  
Comment by dmacd on Nov 15, 2021 11:22pm
Good points. I have accumulated about my limit for these speculative buy mostly derisked value stocks. I plan to hold tight for 3 to 5 years and hope management will value the SP. Thanks!
Comment by dmacd on Nov 16, 2021 9:55am
https://www.reuters.com/business/finance/big-short-burry-exits-bearish-bets-tesla-google-2021-11-16/ From the CEO BBs
Comment by dmacd on Nov 19, 2021 4:48pm
Good volume. Back to breakeven. The payoff has taken a while but it'll be worth it. Very tight share structure.
Comment by JonathanJSmith on Dec 06, 2021 3:16pm
Good presentation today. Also, good to hear that Burry bought almost 800K shares recently. Ibrexa will be a billion+ dollar drug within a few short years; it'll be quite a lucrative franchise as it were. Alas, I will continue to accumulate in my non-IRA accounts under $10/sh. We should see a substantive increase in Rx by next Q. I hope that they don't sell the company too soon. Vedremo ...more  
Comment by dmacd on Jan 21, 2022 3:35pm
Valued at cash again... well plus the long term debt. Expecting $20M burn as sales will take a while. Question is can they avoid another dilution with profits within next 3 or 4 quarters. The new prescription rebilling code was late in quarter and will take a quarter to kick in. Will buy more if the gap looks to be closing, otherwise no more for me. Mario has diluted so much that one wonders if ...more